MRPL3 Recombinant antibody

MRPL3 Uni-rAbTM Recombinant Antibody for WB, ELISA
Cat No. 85327-1-RR
Clone No.242401G9

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

WB, ELISA

MRPL 3, MRP L3, MRL3, L3mt, COXPD9

Formulation:  PBS and Azide
PBS and Azide
PBS Only
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:


Tested Applications

Positive WB detected inHepG2 cells, A431 cells, HeLa cells, HEK-293T cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:5000-1:50000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

85327-1-RR targets MRPL3 in WB, ELISA applications and shows reactivity with human samples.

Tested Reactivity human
Host / Isotype Rabbit / IgG
Class Recombinant
Type Antibody
Immunogen MRPL3 fusion protein Ag9970 Predict reactive species
Full Name mitochondrial ribosomal protein L3
Calculated Molecular Weight 39 kDa
Observed Molecular Weight 35-39 kDa
GenBank Accession NumberBC003375
Gene Symbol MRPL3
Gene ID (NCBI) 11222
Conjugate Unconjugated
Form Liquid
Purification MethodProtein A purification
UNIPROT IDP09001
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

MRPL3, also named as 39S ribosomal protein L3, mitochondrial or RPML3, is a 348 amino acid protein, which belongs to the ribosomal protein L3P family. MRPL3 localizes in the Mitochondrion and has an association with combined oxidative phosphorylation deficiency 9. MRPL3 plays role in the mitochondrial proteins biosynthesis and ribosomal structure and biogenesis.

Protocols

Product Specific Protocols
WB protocol for MRPL3 antibody 85327-1-RRDownload protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...